Coated-platelets predict stroke at 30 days following TIA

Area of Science:

• Hematology
• Neurology
• Cardiovascular Medicine

Background:

• Transient ischemic attack (TIA) is a critical warning sign for future stroke.
• Current risk assessment tools, like the ABCD2 score, have limitations in predicting short-term stroke risk.
• Identifying novel biomarkers for early stroke prediction is crucial for timely intervention.

Purpose of the Study:

• To evaluate the predictive value of coated-platelets for 30-day stroke risk in patients with TIA.
• To compare the performance of coated-platelet levels against the established ABCD2 score for stroke prediction.

Main Methods:

• Prospective enrollment of 171 TIA patients with baseline assessment of coated-platelet levels.
• Follow-up for 30 days to record stroke occurrence as the primary endpoint.
• Receiver operator characteristic (ROC) analysis to determine the predictive accuracy (Area Under the Curve - AUC) of a model incorporating coated-platelets.

Main Results:

• A total of 10 strokes occurred within 30 days.
• Coated-platelet levels ≥51.1% were associated with a 10.72-fold increased risk of stroke.
• The coated-platelet model demonstrated superior predictive ability (AUC 0.78) compared to the ABCD2 score (AUC 0.54), p=0.01.

Conclusions:

• Coated-platelets show significant potential as a biomarker for predicting 30-day stroke risk after TIA.
• This finding suggests a role for coated-platelets in refining stroke risk stratification strategies.
• Further research may incorporate coated-platelets into clinical decision-making for TIA patients.